← Back to Clinical Trials
Recruiting NCT06136260

NCT06136260 The Grief Navigation Trial: A Comparison of Two Interventions to Support Parents After Their Child's Unexpected or Traumatic Death

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06136260
Status Recruiting
Phase —
Sponsor Ann & Robert H Lurie Children's Hospital of Chicago
Condition Bereavement
Study Type INTERVENTIONAL
Enrollment 2,000 participants
Start Date 2024-03-04
Primary Completion 2027-07

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
CommunityRx-BereavementGeneral Bereavement Support Information

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 2,000 participants in total. It began in 2024-03-04 with a primary completion date of 2027-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Parents of children who die traumatically or unexpectedly from things like suicide or an overdose suffer from mental and physical health problems and can experience massive disruptions in their family life. For about half of these parents, the first, and sometimes only, interactions they have with the healthcare system when their child dies are with a medical examiner or coroner (hereafter 'ME'). But MEs have little to no training in helping grieving families, and there are no standards guiding medical examiners or coroners on how or even if they should help grieving families. This gap leaves parents to find the help they need on their own. This research will test two different strategies for addressing this gap in the healthcare system.

Eligibility Criteria

Inclusion Criteria: * Parents or caregivers of ME cases involving a person \< 25 years old from one of the following offices: Cook County Medical Examiners, Lake County Coroners, DuPage County Coroner, Will County Coroner, McHenry County Coroner, Kane County Coroner, Peoria County Coroner * Parents or caregivers who provide permission to the ME to be referred to Missing Pieces * Parent or caregivers who are referred to Missing Pieces by a ME * Parents or caregivers able to read and communicate in English or Spanish Exclusion Criteria: * Parents or caregivers unable to read or communicate in English or Spanish * Parents or caregivers under the age of 18 years old

Contact & Investigator

Central Contact

Kelly Michelson, MD, MPH

✉ kmichelson@luriechildrens.org

📞 312-227-4800

Principal Investigator

Kelly Michelson, MD, MPH

PRINCIPAL INVESTIGATOR

Ann & Robert H Lurie Children's Hospital of Chicago

Frequently Asked Questions

Who can join the NCT06136260 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Bereavement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06136260 currently recruiting?

Yes, NCT06136260 is actively recruiting participants. Contact the research team at kmichelson@luriechildrens.org for enrollment information.

Where is the NCT06136260 trial being conducted?

This trial is being conducted at Chicago, United States, Joliet, United States, Peoria, United States, Saint Charles, United States and 3 additional locations.

Who is sponsoring the NCT06136260 clinical trial?

NCT06136260 is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. The principal investigator is Kelly Michelson, MD, MPH at Ann & Robert H Lurie Children's Hospital of Chicago. The trial plans to enroll 2,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology